Change in Patent Law May Create “Blue” Gene Sequencers

Companies doing heavy-duty genetic research have sought to gain exclusive commercial rights to their work through patents. But patents in genes have proven controversial, prompting an op-ed from Michael Crighton in The New York Times and a vigorous online debate. Rep. Xavier Becerra (D-Cal.) has even introduced a federal bill, the “Genomic Research and Accessibility Act,” which would remove all patent protection for a “nucleotide sequence, or its functions or correlations, or the naturally occurring products it specifies.” As IP Law & Business reports, genetic researchers and their lobbyists are opposing the bill in Congress, and most experts believe the bill stands very little chance of passage.

#1 Legal Research App

Winner of the prestigious American Association of Law Libraries (New Product) Award, Fastcase for iOS, Android, and Windows Phone is used by more attorneys than any other legal app according to the ABA. Anyone may use the app for free to access Fastcase's comprehensive legal research database on the go.